2024年人工智能全景报告英文版-stateof.ai_212页_36mb

报告摘要

Report Focus: A comprehensive analysis of AI advancements across research, industry, politics, safety, and predictions (2023-2024).
Authors: Nathan Benaich (VC at Air Street Capital) and Alex Chalmiers (Platform Lead).

Frontier Models Converge: While OpenAI retains an edge with o1, models like Llama 3 and Gemini demonstrate near-parity with proprietary labs.
Multimodal Advancements: GenAI extends into vision (SAM 2), robotics, and biology (AlphaFold 3, AlphaProteo).
Efficiency & Scaling: Innovations in quantization (BitNet), distillation (FLUX.1), and computational reuse aim to lower barriers.
AGI Challenges: Debate on scaling for human-like reasoning persists amid questions of hallucinations and evaluation limits.
Safety Focus: Emergence of adversarial testing (jailbreaking) and alignment techniques (DPO, RLHF improvements).

NVIDIA Dominance: Continues to lead in compute with Blackwell/B200 GPUs, facing sanctions evasion through intermediaries.
Market Valuations: AI companies reach near-$9T collective value; Chinese models challenge US leadership despite export controls.
Enterprise Integration: Generative AI sees improved revenue retention but faces regulatory hurdles (e.g., EU/US copyright disputes).
Consolidation: Big Tech (Microsoft, Amazon, Apple) use pseudo-acquisitions (e.g., Inﬂection, Adept) to expand influence.

US Regulatory Efforts: Executive Order 14110 mandates pre-deployment safety tests but faces political risks.
Global Fragmentation: EU’s AI Act weakens for sensitive applications, while China enforces strict censorship.
Sanctions & Geopolitics: US ramps up export controls to China; Japan emerges as a niche investor in AI.

Vulnerabilities: Ongoing issues with prompt engineering (jailbreaking) and emergent risks are exploited in real-world attacks.
Interpretability Gains: Progress with sparse autoencoders and feature pinning (Anthropic) sheds light on model internals.
Dual-Use Concerns: Biology and robotics tools spark debate on governance and accessibility, despite limited misuse cases.